Research article summary (published 29 Sep 2009):

Renal and retinal effects of enalapril and losartan in type 1 diabetes.

Full Abstract

No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Tamsma, Jouke T (JT);

Journal and publication information

Publication Type: Comment; Letter

Journal: The New England journal of medicine (N Engl J Med), published in United States. (Language: eng)

Reference: 2009-Oct; vol 361 (issue 14) : pp 1410; author reply 1411

Dates: Created 2009/10/02; Completed 2009/10/06;

PMID: 19797291, status: MEDLINE (last retrieval date: 10/6/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

CommentOn: N Engl J Med. 2009 Jul 2;361(1):40-51. (PMID: 19571282)

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Angiotensin II Type 1 Receptor Blockers - therapeutic use Angiotensin-Converting Enzyme Inhibitors - pharmacology; therapeutic use Diabetes Mellitus, Type 1 - complications; drug therapy Diabetic Nephropathies - etiology; prevention & control Diabetic Retinopathy - prevention & control Disease Progression

Disease Progression Genetic Predisposition to Disease Humans Hypertension - complications; genetics Patient Selection Renin-Angiotensin System - drug effects

Associated Chemicals: Angiotensin II Type 1 Receptor Blockers (0) ; Angiotensin-Converting Enzyme Inhibitors (0)

Related articles

These are the highest related articles currently in the database:

• Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney. 26 Aug 2008
• Renal protection in diabetes: is it affected by glucose control or inhibition of the renin-angiotensin pathway? 28 Feb 2008
• Do agents that block the RAS truly offer renoprotective effects in early stage, nonproteinuric nephropathy? 30 Oct 2007
• Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. 29 Jun 2006
• Does antihypertensive treatment prevent progression of microalbuminuria to overt proteinuria in insulin-dependent diabetic patients? 29 Sep 1992
• Should all diabetic patients take ACE inhibitors, even those without proteinuria? 30 Mar 1999
• From the control tower: some is better than none and a little bit goes a long way. 29 Nov 2001
• Diabetic renal-retinal syndrome: does tight control help? 30 Mar 1987
• Angiotensin blockade in type 2 diabetic renal disease. 29 Nov 2002
• Tight glycemic control? Negative. 30 Jan 1992

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.